Search or
𝛼SK
𝛼SKBCLI: Preparing to Initiate Phase 3b Trial of NurOwn Before End of 2024
On July 8, 2024, BrainStorm Cell Therapeutics, Inc. (BCLI) conducted a mid-year conference call to provide an update on the status of the...
SUMMARY
(Sign Up to Access)Full Insight
(Paid Plans Only, 10-minute read)
Related Insights
More »- BCLI: Focused on Initiation of Phase 3b ENDURANCE Trial of NurOwn in ALS
- BCLI: Citizen's Petition Filed Requesting the FDA Approve NurOwn
- BCLI: Receives Regulatory Clearance to Initiate Phase 3b ALS Trial
- BrainStorm Cell Therapeutics (BCLI) - Fundamentals Update 09042025
- BCLI: Plans Coming Together for Phase 3b Trial of NurOwn in ALS
Trending Collections
More »Trending Insights
More »- MV Australia Equal Weight Index Rebalance Preview: Three Potential Deletions in September
- Lynch Group (LGL AU): (Another) Clean Offer From TPG
- HMM Tender Side Play: Targeting a Basis Squeeze Ahead of Sep Expiry
- Pop Mart (9992 HK): Revenue Up by 204%, Margin Up by 17 PPT, 64% Upside
- Hang Seng Index (HSI) Outlook Ahead of Sep25 Rebalance
Top Unpaywalled Insights
More »- Kyivstar (KYIV US): Structural Long – From Ukraine’s Resilience to Renewal; Uklon Embedded Value
- How to Own Lenovo at a Discount: BUY Legend Holdings Corp (3396 HK)
- Institutions Are Coming for Bitcoin — UTXO’s Loren Asmus Explains How
- Curator's Cut: Singapore Unlocks Value, India’s Jewellery Caution & Taiwan's Top ETF's Rebalance
- [IO Technicals 2025/33] China Woes Deepen, Bearish Momentum Grips Iron Ore
Discussions
(Paid Plans Only)
Price Chart(Sign Up to Access)
- BCLI: Preparing to Initiate Phase 3b Trial of NurOwn Before End of 2024 10 Jul 2024
x